Language selection


Notice of Submission for Approval of Novel Food and Livestock Feed Use for Cotton Genetically Modified for Herbicide Tolerance (MON 88701) from Monsanto Canada Inc.

May 31, 2012
Comment period closed: 2012-12-28


The CFIA and Health Canada have received a submission from Monsanto Canada Inc. seeking an approval for livestock feed and food use of a cotton line designated as MON 88701, which has been genetically modified for dicamba and glufosinate tolerance. The submission received is in accordance with CFIA guidelines for assessment of novel feeds, and Health Canada guidelines for assessment of novel foods. To view information related to the assessment of a novel feed, please refer to the CFIA website. To view the information related to the health and safety assessment of a novel food, please refer to the Health Canada website.

Summary of the Submission Package

Updated scientific information may be added to this submission by the developer at a later date, or CFIA and/or Health Canada may request further information from the developer.

Description of the Host Plant

Please refer to the Organization for Economic Co-operation and Development's Consensus Document on the Biology of Cotton (Gossypium spp.), published.05-Dec-08, . Cotton is not cultivated in Canada.

Description of the Modification

Cotton line MON 88701 was developed through recombinant DNA technology. In order to assess the modification process, the following has been submitted:

Inheritance and Stability of the Introduced Trait

In order to assess the inheritance and stability of the genetic modification, the following has been submitted:

Description of the Introduced Traits

In order to characterize the DNA inserted in the plant, the following has been submitted:

Toxicity of the Novel Gene Products

The toxicity of the DMO and PAT proteins on nontarget species, humans and animals. The following has been submitted to support the application:

Nutritional Evaluation

In order to assess nutritional aspects of the novel plant, the following has been submitted:

Allergenicity/Toxicity Considerations

In order to assess allergenicity and toxicity of the novel proteins, the following has been submitted:

Evaluation of Environmental Impact

In order to assess the environmental impact of MON 88701, the following has been submitted:

For more information on this product, please contact:

Monsanto Canada Inc.
180 Kent Street, Suite 810
Ottawa ON K1P 0B6
(613) 234-5121

The CFIA and Health Canada, including their employees, are not responsible for the content of this Notice of Submission as submitted by the Applicant. All Notices of Submission are the responsibility of the Applicant submitting them and the Applicant does so at its own risk. Submission of this Notice of Submission and its subsequent posting by the CFIA on its Web site does not in any way whatsoever constitute acceptance, approval or certification by the CFIA or Health Canada of the Plant with Novel Trait(s) subject of the Notice of Submission and the CFIA and Health Canada reserve all their rights under all the pertinent legislation that may be applicable. The CFIA and Health Canada in no way whatsoever waives any of their rights under any of the legislation they enforce or administer by way of the CFIA posting this Notice of Submission.

The Applicant is not obliged to provide any information. The Applicant submits information that it chooses to submit. The information that the Applicant voluntarily provides on this Notice of Submission is collected by the CFIA and Health Canada for the purpose of sharing information with the public. Personal Information will be protected under the provisions of the Privacy Act, and will be stored in Personal Information Bank CFIA PPU 125. Information, including personal information, may be accessible or protected as required under the provisions of the Access to Information Act.

Date modified: